The Clinical Observation Of "Yutu Shengshui Fa" In The Treatment Of Cold-dampness-type Lumbar Disc Herniation

Objective:To investigate the clinical features of cold-dampness-type lumbar disc herniation(CDT-LDH)and compare the clinical efficacy of Jiawei Shenzhuo Decoction with meloxicam in order to provide clinical evidence for the clinical application of "Yutu Shengshui Fa".Meanwhile,”Yutu Shengshui Fa" is different from the traditional victory of treating"Shen",and provides reference and ideas to the treatment of cold-dampness-type rheumatism on treating "Pi".Methods:120 patients were admitted to the investigation who visited the Department of Orthopaedics at the Affiliated Hospital of Nanjing University of Chinese Medicine from January 2017 to January 2018.Patients were divided into study group(60 cases)and control group(60 cases)using random number table method.The study group was treated with Jiawei Shenzhu Decoction and the control group was treated with meloxicam(Hongqiang)for 2 weeks.No other treatment for lumbar disc herniation was used during the observation period.JOA low back pain scores,visual analogue scale(VAS),Athens Insomnia Scale(AIS),Hamilton Anxiety Scale(HAMA)were recorded before and 1 week,2weeks,3weeks,4weeks after treatment.The data were statistically analyzed using SPSS.19.0 software.Results:1.There was no significant difference between the two groups of basic data(P>0.05),and they were comparable.2.Total effective rate:The total effective rate in the study group was 90.0%and 75.0%in the control group.The study group was superior to the control group and the difference was significant(P<0.01).3.JOA lower back pain score:The study group was superior to the control group,and the difference was statistically significant at 1 week after treatment(P<0.05),and the difference was significant at 2-4 weeks after treatment(P<0.01).4.Low back pain score:There was no significant difference between the two groups after one week of treatment(P>0.05),and the study group was better than the control group at 2-4 weeks after treatment(P<0.01).5.Lower extremity pain and numbness score:There was no significant difference between the two groups at 1 and 2 weeks after treatment(P>0.05).Compared with the control group at 3 and 4 weeks,the difference was statistically significant(P<0.05).6.Cold chills scale:There was no significant difference between the 1-4 weeks after treatment and before treatment in the control group(P>0.05),and there was a significant difference between the 1-4 weeks after treatment in the study group(P<0.01).7.AIS:The study group was superior to the control group,with statistical significance at 1 week after treatment(P<0.05),significant difference between 2 and 4 weeks(P<0.01).8.HAMA:2-4 after treatment Zhou group was significantly better than the control group(P<0.01).9.Adverse reactions:There were 2 cases in the study group and 3 cases in the control group.All the symptoms relieved after one week.The difference was not statistically significant(P>0.05).Conclusions:1.The clinical symptoms of CDT-LDH are not only manifested in classic cold and dampness syndromes,such as low back pain,lower limb pain and numbness,inconvenience in walking and cold chills,but also be associated with other clinical symptoms such as sleep disturbance,emotional anxiety and so on.2.Both Jiawei Shenzhuo Decoction and meloxicam can effectively improve the clinical symptoms of CDT-LDH,but Jiawei Shenzhuo Decoction is better than Melox in every index which being worthy of clinical promotion.3."Yutu Shengshui Fa" should be used to widen the clinical treatment of XiaJiao rheumatism.It is worth in-depth study.